Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Sales of the firm's cell therapy franchise grew modestly in the fourth quarter amid competing product launches and overall slow uptake within the class.

Parmod Sagar, Chairman and Managing Director of RHI Magnesita, stated that the company aims to achieve 15% margins by second ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

Largo Inc. ("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO) today announces annual production of 9,264 tonnes (20.4 million lbs¹) of vanadium pentoxide ("V2O5") equivalent ...

As global markets navigate the complexities of trade tariffs and mixed economic indicators, investors are increasingly seeking stability in their portfolios. In such an environment, dividend stocks ...

Amaero International (ASX:3DA) is now funded through to commercialisation of defence and aerospace materials – a milestone that’s set to be reached next year, in 2026. Amaero’s $22 million ...

Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...

Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Should you need assistance, please signal a conference specialist ...